{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:03:59Z","timestamp":1790636639264,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.radonc.2023.109739","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T20:55:05Z","timestamp":1686603305000},"page":"109739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literature"],"prefix":"10.1016","volume":"186","author":[{"given":"Rita","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gulliford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim-Moulay","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha B.","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109739_b0005","unstructured":"Cancer research UK. Soft tissue sarcoma incidence statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/soft-tissue-sarcoma\/incidence#heading-Two (2022)."},{"key":"10.1016\/j.radonc.2023.109739_b0010","unstructured":"NHS digital. Detailed statistics get out programme>sarcoma. https:\/\/www.cancerdata.nhs.uk\/getdataout\/sarcoma."},{"key":"10.1016\/j.radonc.2023.109739_b0015","first-page":"1","article-title":"Bone and soft tissue sarcomas UK incidence and survival : 1996 to 2010 November 2013","volume":"2","author":"Francis","year":"2013","journal-title":"Natl Cancer Intell Netw"},{"key":"10.1016\/j.radonc.2023.109739_b0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/0284186X.2012.709947","article-title":"Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy","volume":"52","author":"Felderhof","year":"2013","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2023.109739_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2012.01.062","article-title":"Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where?","author":"Haas","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O\u2019Sullivan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109739_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.prro.2021.04.005","article-title":"Radiation therapy for treatment of soft tissue sarcoma in adults: Executive summary of an ASTRO clinical practice guideline","volume":"11","author":"Salerno","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0040","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","article-title":"Consequential late effects in normal tissues","volume":"61","author":"D\u00f6rr","year":"2001","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2016.06.021","article-title":"Vortex trial: A randomized controlled multicenter phase 3 trial of volume of postoperative radiation therapy given to adult patients with extremity soft tissue sarcoma (STS)","volume":"96","author":"Robinson","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","article-title":"Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 trial ISRCTN 47772397","volume":"76","author":"Gulliford","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0070","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2020.01.003","article-title":"Derivation of dose\/volume constraints for the anorectum from clinician- and patient-reported outcomes in the CHHiP trial of radiation therapy fractionation","volume":"106","author":"Wilkins","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0080","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2008.12.006","article-title":"Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: Relationship to irradiated bone length, volume, tumor location and dose","volume":"75","author":"Dickie","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0085","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","article-title":"Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: Results of radiation therapy oncology group RTOG-0630 trial","volume":"33","author":"Wang","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0090","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.radonc.2023.109739_b0095","unstructured":"Steel, G. G. Basic clinical radiobiology. (Arnold, 1997)."},{"key":"10.1016\/j.radonc.2023.109739_b0100","article-title":"Is 5 the new 25? long-term oncologic outcomes from a phase II, prospective, 5-fraction preoperative radiation therapy trial in patients with localized soft tissue sarcoma","volume":"7","author":"Bedi","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.radonc.2023.109739_b0110","doi-asserted-by":"crossref","first-page":"20190252","DOI":"10.1259\/bjr.20190252","article-title":"Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation","volume":"92","author":"Di Brina","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109739_b0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13014-019-1207-2","article-title":"Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience","volume":"14","author":"Peeken","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000236","article-title":"Preoperative radiosurgery for soft tissue sarcoma","volume":"41","author":"Kubicek","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2010.02.067","article-title":"Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma","volume":"80","author":"Devisetty","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0130","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2147\/OTT.S88227","article-title":"Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall","volume":"8","author":"Wang","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.radonc.2023.109739_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2009.06.010","article-title":"Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma","author":"Stewart","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0140","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.21873\/anticanres.11044","article-title":"Postoperative radiotherapy after limb-sparing surgery for soft-tissue sarcomas of the distal extremities","volume":"36","author":"Kim","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109739_b0145","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","article-title":"A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma","volume":"26","author":"Kalbasi","year":"2020","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.radonc.2023.109739_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0155","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/cncr.27951","article-title":"Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma","volume":"119","author":"O\u2019Sullivan","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109739_b0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2012.01.074","article-title":"Long-term results following postoperative radiotherapy for soft tissue sarcomas of the extremity","volume":"84","author":"McGee","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0165","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ijrobp.2011.09.047","article-title":"Dose\u2013effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity","volume":"83","author":"Pak","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0170","first-page":"1641","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kose\u0142a-Paterczyk","year":"2014","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0175","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.4081\/rt.2013.e55","article-title":"Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients","volume":"5","author":"Cai","year":"2013","journal-title":"Rare Tumors"},{"key":"10.1016\/j.radonc.2023.109739_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2000\/126837","article-title":"Intensified adjuvant IFADIC chemotherapy for adult soft tissue sarcoma: A prospective randomized feasibility trial","volume":"4","author":"Brodowicz","year":"2000","journal-title":"Sarcoma"},{"key":"10.1016\/j.radonc.2023.109739_b0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/1413-785220192704217574","article-title":"Long-term results of extremity soft tissue sarcomas limb-sparing surgery and radiotherapy","volume":"27","author":"Dogan","year":"2019","journal-title":"Acta Ortop Bras"},{"key":"10.1016\/j.radonc.2023.109739_b0190","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-012-2797-1","article-title":"Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface","volume":"20","author":"Baldini","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2006.11.035","article-title":"Radiation therapy for control of soft-tissue sarcomas resected with positive margins","author":"DeLaney","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0200","doi-asserted-by":"crossref","first-page":"e205865","DOI":"10.1001\/jamaoncol.2020.5865","article-title":"Dose reduction of preoperative radiotherapy in myxoid liposarcoma: A nonrandomized controlled trial","volume":"7","author":"Lansu","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0205","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2008.16.6249","article-title":"Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity","volume":"26","author":"Alektiar","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0210","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.53.9452","article-title":"Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity","author":"Folkert","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0215","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2003.11.037","article-title":"Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh","volume":"59","author":"Hong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0220","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1080\/0284186X.2021.1971294","article-title":"A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma","volume":"60","author":"van Meekeren","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0225","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1016\/j.prro.2022.02.013","article-title":"Dosimetric comparison of volumetric modulated arc therapy and intensity modulated radiation therapy for soft tissue sarcoma of the extremities","volume":"12","author":"Lawless","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0230","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1245\/s10434-020-09213-y","article-title":"Femoral fracture in primary soft tissue sarcoma treated with intensity-modulated radiation therapy with and without dose constraints","volume":"28","author":"Casey","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2023.109739_b0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/13577149977587","article-title":"Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy","volume":"3","author":"Jacob","year":"1999","journal-title":"Sarcoma"},{"key":"10.1016\/j.radonc.2023.109739_b0240","doi-asserted-by":"crossref","unstructured":"D., W. et al. Significant reduction of radiation related morbidities in the extremity sarcoma patients treated with image guided radiation therapy to reduced target volume: Results of RTOG 0630. Int. J. Radiat. Oncol. Biol. Phys. (2013) doi:10.1016\/j.ijrobp.2013.06.164.","DOI":"10.1016\/j.ijrobp.2013.06.164"},{"key":"10.1016\/j.radonc.2023.109739_b0245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijrobp.2015.07.2263","article-title":"Evaluation of the risk of grade 3 oral and pharyngeal dysphagia using atlas-based method and multivariate analyses of individual patient dose distributions","volume":"93","author":"Otter","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0250","doi-asserted-by":"crossref","first-page":"20140543","DOI":"10.1259\/bjr.20140543","article-title":"Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment","volume":"87","author":"Mazzola","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109739_b0255","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/j.ijrobp.2011.04.038","article-title":"RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies","volume":"81","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109739_b0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphys.2020.00137","article-title":"The unresolved pathophysiology of lymphedema","volume":"11","author":"Azhar","year":"2020","journal-title":"Front Physiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:25:57Z","timestamp":1759123557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023002773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"alternative-id":["S0167814023002773"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109739","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109739"}}